Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Capecitabine × Clear all

NCT07254962 2025-11-28

CAPTURE

Phase 2 Not yet recruiting

Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT00258310 2023-03-10

Ph II Long Term/Low Dose Xeloda in Head and Neck Squamous Cell Carcinoma After Surgery, Radiation & or Chemo

Phase 2 Completed

35 enrolled 7 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00266279 2020-09-03

Phase II (Treatment) Study of Oxaliplatin and Capecitabine in Advanced Head and Neck Malignancies

Phase 2 Completed

17 enrolled 6 charts

Head and Neck Neoplasms

NCT03678649 2018-09-19

A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC

Phase 2 Unknown

Head and Neck Neoplasms

NCT00095901 2018-03-29

Capecitabine For Nasopharyngeal Cancer

Phase 2 Completed

Head and Neck Neoplasms

NCT00101075 2017-02-27

Title XELOX FOR SALIVARY GLAND CANCERS

Phase 2 Terminated

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00448552 2016-12-15

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00216138 2011-05-02

Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck

Phase 2 Terminated

Head and Neck Neoplasms